These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30853425)

  • 1. Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors.
    Onder G; Vetrano DL; Villani ER; Carfì A; Lo Monaco MR; Cipriani MC; Manes Gravina E; Denkinger M; Pagano F; van der Roest HG; Bernabei R
    J Am Med Dir Assoc; 2019 Sep; 20(9):1116-1120. PubMed ID: 30853425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
    Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
    Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework.
    Thorpe C; Niznik J; Li A
    BMC Geriatr; 2023 Aug; 23(1):469. PubMed ID: 37542226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Polypharmacy With 1-Year Trajectories of Cognitive and Physical Function in Nursing Home Residents: Results From a Multicenter European Study.
    Vetrano DL; Villani ER; Grande G; Giovannini S; Cipriani MC; Manes-Gravina E; Bernabei R; Onder G
    J Am Med Dir Assoc; 2018 Aug; 19(8):710-713. PubMed ID: 29861194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing medication use in nursing home residents with life-limiting disease.
    Paque K; Elseviers M; Vander Stichele R; Pardon K; Vinkeroye C; Deliens L; Christiaens T; Dilles T
    Eur J Clin Pharmacol; 2019 Jul; 75(7):969-977. PubMed ID: 30834473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis.
    Kua CH; Mak VSL; Huey Lee SW
    J Am Med Dir Assoc; 2019 Mar; 20(3):362-372.e11. PubMed ID: 30581126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing Opportunities for Frail Residents of Nursing Homes: A Multicenter Study in Australia, China, Japan, and Spain.
    Liau SJ; Zhao M; Hamada S; Gutiérrez-Valencia M; Jadczak AD; Li L; Martínez-Velilla N; Sakata N; Fu P; Visvanathan R; Lalic S; Roncal-Belzunce V; Bell JS
    J Am Med Dir Assoc; 2024 May; 25(5):876-883. PubMed ID: 38423513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes towards deprescribing: The perspectives of geriatric patients and nursing home residents.
    Lundby C; Glans P; Simonsen T; Søndergaard J; Ryg J; Lauridsen HH; Pottegård A
    J Am Geriatr Soc; 2021 Jun; 69(6):1508-1518. PubMed ID: 33598916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 Nov; 21(1):655. PubMed ID: 34798826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study.
    Vetrano DL; Tosato M; Colloca G; Topinkova E; Fialova D; Gindin J; van der Roest HG; Landi F; Liperoti R; Bernabei R; Onder G;
    Alzheimers Dement; 2013 Sep; 9(5):587-93. PubMed ID: 23232271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy in nursing home in Europe: results from the SHELTER study.
    Onder G; Liperoti R; Fialova D; Topinkova E; Tosato M; Danese P; Gallo PF; Carpenter I; Finne-Soveri H; Gindin J; Bernabei R; Landi F;
    J Gerontol A Biol Sci Med Sci; 2012 Jun; 67(6):698-704. PubMed ID: 22219520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are residents of aged care facilities willing to have their medications deprescribed?
    Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
    Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia.
    Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Hanson LC; Nace D; Thorpe JM; Thorpe CT
    J Am Geriatr Soc; 2020 Apr; 68(4):699-707. PubMed ID: 31769507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication use in a cohort of newly admitted nursing home residents (Ageing@NH) in relation to evolving physical and mental health.
    Ivanova I; Wauters M; Stichele RV; Christiaens T; De Wolf J; Dilles T; Elseviers M
    Arch Gerontol Geriatr; 2018; 75():202-208. PubMed ID: 29353187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia.
    Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT
    J Am Geriatr Soc; 2019 Sep; 67(9):1871-1879. PubMed ID: 31162642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study.
    Onder G; Liperoti R; Foebel A; Fialova D; Topinkova E; van der Roest HG; Gindin J; Cruz-Jentoft AJ; Fini M; Gambassi G; Bernabei R;
    J Am Med Dir Assoc; 2013 Jun; 14(6):450.e7-12. PubMed ID: 23647778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
    Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
    J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.